IL182493A0 - Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists - Google Patents
Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonistsInfo
- Publication number
- IL182493A0 IL182493A0 IL182493A IL18249307A IL182493A0 IL 182493 A0 IL182493 A0 IL 182493A0 IL 182493 A IL182493 A IL 182493A IL 18249307 A IL18249307 A IL 18249307A IL 182493 A0 IL182493 A0 IL 182493A0
- Authority
- IL
- Israel
- Prior art keywords
- preventing
- receptor antagonists
- adenosine receptor
- pulmonary inflammation
- airway remodeling
- Prior art date
Links
- 101150078577 Adora2b gene Proteins 0.000 title 1
- 208000036065 Airway Remodeling Diseases 0.000 title 1
- 206010035664 Pneumonia Diseases 0.000 title 1
- 229940121359 adenosine receptor antagonist Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000296 purinergic P1 receptor antagonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61943904P | 2004-10-15 | 2004-10-15 | |
| PCT/US2005/036950 WO2006044610A1 (en) | 2004-10-15 | 2005-10-14 | Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL182493A0 true IL182493A0 (en) | 2007-09-20 |
Family
ID=35677798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL182493A IL182493A0 (en) | 2004-10-15 | 2007-04-12 | Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20060159627A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2311462A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2008516969A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20070063548A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101039677A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005295654B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2583986A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL182493A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007004373A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20072466L (cg-RX-API-DMAC7.html) |
| NZ (2) | NZ589657A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2391103C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006044610A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE47351E1 (en) | 1999-06-22 | 2019-04-16 | Gilead Sciences, Inc. | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists |
| US6403567B1 (en) * | 1999-06-22 | 2002-06-11 | Cv Therapeutics, Inc. | N-pyrazole A2A adenosine receptor agonists |
| CA2671940A1 (en) | 2000-02-23 | 2001-08-30 | Cv Therapeutics, Inc. | Identification of partial agonists of the a2a adenosine receptor |
| WO2004011010A1 (en) * | 2002-07-29 | 2004-02-05 | Cv Therapeutics, Inc. | Myocardial perfusion imaging using a2a receptor agonists |
| EP1658291B1 (en) * | 2003-08-25 | 2013-10-02 | Dogwood Pharmaceuticals, Inc. | Substituted 8-heteroaryl xanthines |
| EP1802317A2 (en) * | 2004-10-20 | 2007-07-04 | Cv Therapeutics, Inc. | Use of a2a adenosine receptor agonists |
| US7598379B2 (en) * | 2005-02-25 | 2009-10-06 | Pgx Health, Llc | Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| WO2006091897A2 (en) * | 2005-02-25 | 2006-08-31 | Adenosine Therapeutics, Llc | Derivatives of 8-substituted xanthines |
| WO2006091898A2 (en) * | 2005-02-25 | 2006-08-31 | Adenosine Therapeutics, Llc | Pyrazolyl substituted xanthines |
| CA2612344A1 (en) * | 2005-06-16 | 2006-12-28 | Cv Therapeutics, Inc. | Prodrugs of a2b adenosine receptor antagonists |
| CA2636990A1 (en) * | 2006-01-13 | 2007-07-26 | Battelle Memorial Institute | Animal model for assessing copd-related diseases |
| CA2640089C (en) | 2006-02-03 | 2013-07-23 | Cv Therapeutics, Inc. | Process for preparing an a2a-adenosine receptor agonist and its polymorphs |
| US7884100B2 (en) * | 2006-06-16 | 2011-02-08 | Pgxhealth, Llc | Substituted 8-[6-amino-3-pyridyl]xanthines |
| US7767685B2 (en) * | 2006-06-29 | 2010-08-03 | King Pharmaceuticals Research And Development, Inc. | Adenosine A2B receptor antagonists |
| US20090081120A1 (en) * | 2006-09-01 | 2009-03-26 | Cv Therapeutics, Inc. | Methods and Compositions for Increasing Patient Tolerability During Myocardial Imaging Methods |
| MX2009002299A (es) * | 2006-09-01 | 2009-03-20 | Cv Therapeutics Inc | Metodos y composiciones para incrementar la tolerancia del paciente durante metodos de formacion de imagenes del miocardio. |
| WO2008042796A2 (en) * | 2006-09-29 | 2008-04-10 | Cv Therapeutics, Inc. | Methods for myocardial imaging in patients having a history of pulmonary disease |
| EP2099360A2 (en) * | 2007-01-03 | 2009-09-16 | CV Therapeutics Inc. | Myocardial perfusion imaging |
| JP5460690B2 (ja) * | 2008-03-26 | 2014-04-02 | アドヴィナス・セラピューティックス・リミテッド | アデノシンレセプターアンタゴニストとしてのヘテロ環化合物 |
| KR20110063556A (ko) * | 2008-09-29 | 2011-06-10 | 길리애드 사이언시즈, 인코포레이티드 | 다검출 전산화 단층 촬영법에 사용하기 위한 a-2-알파 수용체 길항제와 속도 조절제의 조합물 |
| BRPI1009398A2 (pt) * | 2009-03-13 | 2016-03-08 | Advinus Therapeutics Private Ltd | compostos de pirimidina fundida substituída |
| KR20130088834A (ko) * | 2010-06-30 | 2013-08-08 | 길리애드 사이언시즈, 인코포레이티드 | 폐 고혈압의 치료를 위한 a2b 아데노신 수용체 길항제의 용도 |
| AR085942A1 (es) | 2011-04-07 | 2013-11-06 | Gilead Sciences Inc | Uso de receptor de aadenosina para tratar la insuficiencia cardiaca y la arritmia en pacientes posinfarto de miocardio |
| CN107249630A (zh) * | 2014-11-24 | 2017-10-13 | 国家健康与医学研究院 | 通过il‑20r的拮抗作用治疗慢性阻塞性肺疾病的急性加重 |
| ES2580702B1 (es) | 2015-02-25 | 2017-06-08 | Palobiofarma, S.L. | Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina |
| JP7849948B2 (ja) | 2018-03-05 | 2026-04-22 | テオン セラピューティクス,インク. | アデノシン受容体アンタゴニストおよびその使用 |
| EP4211135A1 (en) * | 2020-09-04 | 2023-07-19 | Teon Therapeutics, Inc. | Cocrystals of an adenosine a2b receptor antagonist |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| US5854081A (en) | 1996-06-20 | 1998-12-29 | The University Of Patent Foundation | Stable expression of human A2B adenosine receptors, and assays employing the same |
| US6117878A (en) * | 1998-02-24 | 2000-09-12 | University Of Virginia | 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors |
| US6545002B1 (en) | 1999-06-01 | 2003-04-08 | University Of Virginia Patent Foundation | Substituted 8-phenylxanthines useful as antagonists of A2B adenosine receptors |
| US6815446B1 (en) | 1999-08-31 | 2004-11-09 | Vanderbilt University | Selective antagonists of A2B adenosine receptors |
| BR0013673A (pt) * | 1999-08-31 | 2002-05-28 | Univ Vanderbilt | Antagonistas seletivos de receptores de adenosina a2b |
| IL133680A0 (en) * | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| US6894021B2 (en) | 2000-02-17 | 2005-05-17 | Cv Therapeutics, Inc. | Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| US6387913B1 (en) * | 2000-12-07 | 2002-05-14 | S. Jamal Mustafa | Method of treating airway diseases with combined administration of A2B and A3 adenosine receptor antagonists |
| US20030235555A1 (en) * | 2002-04-05 | 2003-12-25 | David Shealey | Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses |
| US7304070B2 (en) | 2001-11-09 | 2007-12-04 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
| US7125993B2 (en) * | 2001-11-09 | 2006-10-24 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
| US20080318983A1 (en) | 2001-11-09 | 2008-12-25 | Rao Kalla | A2b adenosine receptor antagonists |
| US7317017B2 (en) | 2002-11-08 | 2008-01-08 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
| US6977300B2 (en) * | 2001-11-09 | 2005-12-20 | Cv Therapeutics, Inc. | A2B adenosine receptor antagonists |
| AU2002359365B2 (en) * | 2001-11-09 | 2008-07-10 | Gilead Sciences, Inc. | A2B adenosine receptor antagonists |
| US6933298B2 (en) * | 2001-12-08 | 2005-08-23 | Aventis Pharma Deutschland Gmbh | Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenases |
| KR20040068317A (ko) * | 2001-12-20 | 2004-07-30 | 오에스아이 파마슈티컬스, 인코포레이티드 | 피리미딘 a₂b 선택성 길항 화합물, 그의 합성 방법 및용도 |
| ES2229928B1 (es) | 2003-10-02 | 2006-07-01 | Almirall Prodesfarma, S.A. | Nuevos derivados de pirimidin-2-amina. |
| US7449473B2 (en) | 2003-10-31 | 2008-11-11 | Cv Therapeutics, Inc. | Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine receptor antagonists |
| PL1789053T3 (pl) | 2004-09-01 | 2012-12-31 | Gilead Sciences Inc | Sposób gojenia się rany wykorzystujący antagonistów receptora adenozynowego A2B |
| CA2612344A1 (en) | 2005-06-16 | 2006-12-28 | Cv Therapeutics, Inc. | Prodrugs of a2b adenosine receptor antagonists |
| CA2646333C (en) | 2006-03-17 | 2014-06-17 | Cv Therapeutics, Inc. | Method of preventing and treating hepatic disease using a2b adenosine receptor antagonists |
-
2005
- 2005-10-14 EP EP10011664A patent/EP2311462A1/en not_active Withdrawn
- 2005-10-14 NZ NZ589657A patent/NZ589657A/en not_active IP Right Cessation
- 2005-10-14 CA CA002583986A patent/CA2583986A1/en not_active Abandoned
- 2005-10-14 AU AU2005295654A patent/AU2005295654B2/en not_active Ceased
- 2005-10-14 WO PCT/US2005/036950 patent/WO2006044610A1/en not_active Ceased
- 2005-10-14 NZ NZ554485A patent/NZ554485A/en not_active IP Right Cessation
- 2005-10-14 US US11/251,450 patent/US20060159627A1/en not_active Abandoned
- 2005-10-14 JP JP2007536923A patent/JP2008516969A/ja active Pending
- 2005-10-14 EP EP05808733A patent/EP1799221A1/en not_active Withdrawn
- 2005-10-14 CN CNA200580034824XA patent/CN101039677A/zh active Pending
- 2005-10-14 RU RU2007117907/14A patent/RU2391103C2/ru not_active IP Right Cessation
- 2005-10-14 KR KR1020077008536A patent/KR20070063548A/ko not_active Ceased
- 2005-10-14 MX MX2007004373A patent/MX2007004373A/es unknown
-
2007
- 2007-04-12 IL IL182493A patent/IL182493A0/en unknown
- 2007-05-14 NO NO20072466A patent/NO20072466L/no not_active Application Discontinuation
-
2009
- 2009-10-26 US US12/605,783 patent/US8466129B2/en not_active Expired - Lifetime
-
2011
- 2011-12-19 JP JP2011277345A patent/JP2012056965A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NZ589657A (en) | 2012-06-29 |
| WO2006044610A1 (en) | 2006-04-27 |
| RU2391103C2 (ru) | 2010-06-10 |
| CN101039677A (zh) | 2007-09-19 |
| JP2008516969A (ja) | 2008-05-22 |
| US8466129B2 (en) | 2013-06-18 |
| EP2311462A1 (en) | 2011-04-20 |
| NZ554485A (en) | 2010-12-24 |
| JP2012056965A (ja) | 2012-03-22 |
| RU2007117907A (ru) | 2008-11-20 |
| US20060159627A1 (en) | 2006-07-20 |
| NO20072466L (no) | 2007-05-14 |
| US20100105706A1 (en) | 2010-04-29 |
| MX2007004373A (es) | 2007-08-08 |
| KR20070063548A (ko) | 2007-06-19 |
| AU2005295654A1 (en) | 2006-04-27 |
| CA2583986A1 (en) | 2006-04-27 |
| EP1799221A1 (en) | 2007-06-27 |
| AU2005295654B2 (en) | 2011-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200807894B (en) | Method of preventing and treating hepatic disease using A2B adenosine receptor antagonists | |
| IL181634A0 (en) | Method of wound healing using a2b adenosine receptor antagonists | |
| IL181325A0 (en) | Air-launchable aircraft and method of use | |
| GB0509126D0 (en) | Internal riser inspection system, apparatus and methods of using same | |
| GB2413184B (en) | Internal riser inspection device and methods of using same | |
| IL196763A0 (en) | Non-flushing niacin analogues, and methods of use thereof | |
| IL178365A0 (en) | Selective antagonists of a2a adenosine receptors | |
| IL182115A0 (en) | Steroid analogs and characterization and treatment methods | |
| ZA200701635B (en) | Quinazolinone derivatives and their use as B-Raf inhibitors | |
| ZA200701366B (en) | Quinazolinone derivatives and their use as B-Raf inhibitors | |
| GB0508218D0 (en) | Online thermal and watercut management | |
| GB2447581B (en) | Articulated drillstring entry apparatus and method | |
| GB0514950D0 (en) | Downhole measurement system and method | |
| IL181898A0 (en) | Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same | |
| GB0611154D0 (en) | Novel receptor antagonists and their methods of use | |
| EP1811713A4 (en) | METHOD FOR DETERMINING THE CLOCK TRACKING PATH AND METHOD FOR TAKING TRACKING IN THE NETWORK | |
| SI1786744T1 (sl) | Postopek za zaviranje vezave mavca in pripravkov iz mavca | |
| PL1751175T3 (pl) | Antagoniści receptora IL-1, kompozycje i sposoby leczenia | |
| GB0707743D0 (en) | Rock bolt and method of use | |
| IL178785A0 (en) | Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension | |
| GB2454112B (en) | Apparatus and method for use in suspending loads in wellbore operations | |
| EP1838730A4 (en) | PAN-HER ANTAGONISTS AND METHODS OF USE | |
| GB0415516D0 (en) | Apparatus and method of using the same | |
| HK1109728A (en) | Method of preventing and treating airway remodeling and pulmonary inflammation using a2b adenosine receptor antagonists | |
| SG123633A1 (en) | System and method for detecting of pulmonary diseases |